Aegis Daily FacialSPF 25 (JNTLee Inc. dba Panacea)
Welcome to the PulseAid listing for the Aegis Daily Facial drug offered from JNTLee Inc. dba Panacea. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | JNTLee Inc. dba Panacea |
NON-PROPRIETARY NAME: | AVOBENZONE, HOMOSALATE, OCTINOXATE, OCTISALATE, and OCTOCRYLENE |
SUBSTANCE NAME: | AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | LOTION |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 2017-10-20 |
END MARKETING DATE: | 0000-00-00 |
Aegis Daily Facial SPF 25 HUMAN OTC DRUG Details:
Item Description | Aegis Daily Facial SPF 25 from JNTLee Inc. dba Panacea |
LABELER NAME: | JNTLee Inc. dba Panacea |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 29; 90; 68; 45; 50(mg/mL; mg/mL; mg/mL; mg/mL; mg/mL) |
START MARKETING DATE: | 2017-10-20 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 71690-201_3fa98c98-03ae-4c00-beb7-3b0b49f46a78 |
PRODUCT NDC: | 71690-201 |
APPLICATION NUMBER: | part352 |
Other AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE Pharmaceutical Manufacturers / Labelers: